First UK patient cohort treated with stereotactic ablative radiotherapy for primary kidney cancer

First UK patient cohort treated with stereotactic ablative radiotherapy for primary kidney cancer

Abstract Aims Stereotactic ablative radiotherapy (SABR) for primary renal cell carcinoma (RCC) is a promising non‐invasive ablative treatment option. A prospective interventional clinical trial published showed that treatment was feasible and well tolerated. We present the first single‐institution U...

Full description

Bibliographic Details
Main Authors: Anjali Zarkar, Dan Henderson, Antony Carver, Geoff Heyes, Victoria Harrop, Sarah Tutill, Julie Kilkenny, Andrea Marshall, Nada Elbeltagi, Helen Howard
Format: Article
Language:English
Published: Wiley 2023-07-01
Series:BJUI Compass
Subjects:
primary kidney SABR
SABR
SABR for primary RCC
SBRT
SBRT for primary RCC
stereotactic ablative radiotherapy
Online Access:https://doi.org/10.1002/bco2.199

Internet

https://doi.org/10.1002/bco2.199

Similar Items